Differential reactivities of recombinant glycosylated ectodomains of mouse and human thyrotropin receptors with patient autoantibodies

Sai A. Patibandla, Gattadahalli Seetharamaiah, John S. Dallas, N. Rao Thotakura, Robert L. Peake, Bellur S. Prabhakar

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

We expressed the extracellular domain of the mouse TSH receptor (mET- gp) using the baculovirus expression system. The recombinant protein was identified as mET-gp by immunoblotting and N-terminal amino acid sequencing. Carbohydrate analysis of the recombinant protein showed that the protein is glycosylated. Experimental antibodies raised against the extracellular domain of the human TSHr (ETSHr) were assayed for reactivity against mET-gp and glycosylated human ETSHr (ETSHr-gp) in an ELISA and found to be comparable. Similarly, both mET-gp and ETSHr-gp proteins neutralized the TSH binding inhibitory immunoglobulin (TBII) activity of rabbit anti-ET-SHr antibodies in a RRA. However, when these proteins were compared for their ability to neutralize TBII and blocking activities (TSBAb) of IgG from patients with thyroid autoimmune disorders, only ETSHr-gp was able to neutralize these activities. In contrast, mET-gp partially neutralized, whereas ETSHr-gp completely neutralized the stimulatory (TSAb) activities of IgG from patients. Analyses of reactivities of these two proteins against a panel of antipeptide and monoclonal antibodies and their protein sequences showed differences in some specific epitopes. These data showed that in spite of significant homology between the two proteins, they exhibit specific epitope differences that are sufficient to cause divergence in their ability to react with patient autoantibodies to TSHr. This suggests that the two proteins might differ in their three-dimensional structure.

Original languageEnglish (US)
Pages (from-to)1559-1566
Number of pages8
JournalEndocrinology
Volume138
Issue number4
DOIs
StatePublished - 1997
Externally publishedYes

Fingerprint

Thyrotropin Receptors
Autoantibodies
Proteins
Recombinant Proteins
Epitopes
Immunoglobulin G
Antibodies
Baculoviridae
Protein Sequence Analysis
Immunoblotting
Thyroid Gland
Enzyme-Linked Immunosorbent Assay
Monoclonal Antibodies
Carbohydrates
Rabbits

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Differential reactivities of recombinant glycosylated ectodomains of mouse and human thyrotropin receptors with patient autoantibodies. / Patibandla, Sai A.; Seetharamaiah, Gattadahalli; Dallas, John S.; Thotakura, N. Rao; Peake, Robert L.; Prabhakar, Bellur S.

In: Endocrinology, Vol. 138, No. 4, 1997, p. 1559-1566.

Research output: Contribution to journalArticle

Patibandla, Sai A. ; Seetharamaiah, Gattadahalli ; Dallas, John S. ; Thotakura, N. Rao ; Peake, Robert L. ; Prabhakar, Bellur S. / Differential reactivities of recombinant glycosylated ectodomains of mouse and human thyrotropin receptors with patient autoantibodies. In: Endocrinology. 1997 ; Vol. 138, No. 4. pp. 1559-1566.
@article{0209c8318138468fb4a556a26546d0f3,
title = "Differential reactivities of recombinant glycosylated ectodomains of mouse and human thyrotropin receptors with patient autoantibodies",
abstract = "We expressed the extracellular domain of the mouse TSH receptor (mET- gp) using the baculovirus expression system. The recombinant protein was identified as mET-gp by immunoblotting and N-terminal amino acid sequencing. Carbohydrate analysis of the recombinant protein showed that the protein is glycosylated. Experimental antibodies raised against the extracellular domain of the human TSHr (ETSHr) were assayed for reactivity against mET-gp and glycosylated human ETSHr (ETSHr-gp) in an ELISA and found to be comparable. Similarly, both mET-gp and ETSHr-gp proteins neutralized the TSH binding inhibitory immunoglobulin (TBII) activity of rabbit anti-ET-SHr antibodies in a RRA. However, when these proteins were compared for their ability to neutralize TBII and blocking activities (TSBAb) of IgG from patients with thyroid autoimmune disorders, only ETSHr-gp was able to neutralize these activities. In contrast, mET-gp partially neutralized, whereas ETSHr-gp completely neutralized the stimulatory (TSAb) activities of IgG from patients. Analyses of reactivities of these two proteins against a panel of antipeptide and monoclonal antibodies and their protein sequences showed differences in some specific epitopes. These data showed that in spite of significant homology between the two proteins, they exhibit specific epitope differences that are sufficient to cause divergence in their ability to react with patient autoantibodies to TSHr. This suggests that the two proteins might differ in their three-dimensional structure.",
author = "Patibandla, {Sai A.} and Gattadahalli Seetharamaiah and Dallas, {John S.} and Thotakura, {N. Rao} and Peake, {Robert L.} and Prabhakar, {Bellur S.}",
year = "1997",
doi = "10.1210/en.138.4.1559",
language = "English (US)",
volume = "138",
pages = "1559--1566",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "4",

}

TY - JOUR

T1 - Differential reactivities of recombinant glycosylated ectodomains of mouse and human thyrotropin receptors with patient autoantibodies

AU - Patibandla, Sai A.

AU - Seetharamaiah, Gattadahalli

AU - Dallas, John S.

AU - Thotakura, N. Rao

AU - Peake, Robert L.

AU - Prabhakar, Bellur S.

PY - 1997

Y1 - 1997

N2 - We expressed the extracellular domain of the mouse TSH receptor (mET- gp) using the baculovirus expression system. The recombinant protein was identified as mET-gp by immunoblotting and N-terminal amino acid sequencing. Carbohydrate analysis of the recombinant protein showed that the protein is glycosylated. Experimental antibodies raised against the extracellular domain of the human TSHr (ETSHr) were assayed for reactivity against mET-gp and glycosylated human ETSHr (ETSHr-gp) in an ELISA and found to be comparable. Similarly, both mET-gp and ETSHr-gp proteins neutralized the TSH binding inhibitory immunoglobulin (TBII) activity of rabbit anti-ET-SHr antibodies in a RRA. However, when these proteins were compared for their ability to neutralize TBII and blocking activities (TSBAb) of IgG from patients with thyroid autoimmune disorders, only ETSHr-gp was able to neutralize these activities. In contrast, mET-gp partially neutralized, whereas ETSHr-gp completely neutralized the stimulatory (TSAb) activities of IgG from patients. Analyses of reactivities of these two proteins against a panel of antipeptide and monoclonal antibodies and their protein sequences showed differences in some specific epitopes. These data showed that in spite of significant homology between the two proteins, they exhibit specific epitope differences that are sufficient to cause divergence in their ability to react with patient autoantibodies to TSHr. This suggests that the two proteins might differ in their three-dimensional structure.

AB - We expressed the extracellular domain of the mouse TSH receptor (mET- gp) using the baculovirus expression system. The recombinant protein was identified as mET-gp by immunoblotting and N-terminal amino acid sequencing. Carbohydrate analysis of the recombinant protein showed that the protein is glycosylated. Experimental antibodies raised against the extracellular domain of the human TSHr (ETSHr) were assayed for reactivity against mET-gp and glycosylated human ETSHr (ETSHr-gp) in an ELISA and found to be comparable. Similarly, both mET-gp and ETSHr-gp proteins neutralized the TSH binding inhibitory immunoglobulin (TBII) activity of rabbit anti-ET-SHr antibodies in a RRA. However, when these proteins were compared for their ability to neutralize TBII and blocking activities (TSBAb) of IgG from patients with thyroid autoimmune disorders, only ETSHr-gp was able to neutralize these activities. In contrast, mET-gp partially neutralized, whereas ETSHr-gp completely neutralized the stimulatory (TSAb) activities of IgG from patients. Analyses of reactivities of these two proteins against a panel of antipeptide and monoclonal antibodies and their protein sequences showed differences in some specific epitopes. These data showed that in spite of significant homology between the two proteins, they exhibit specific epitope differences that are sufficient to cause divergence in their ability to react with patient autoantibodies to TSHr. This suggests that the two proteins might differ in their three-dimensional structure.

UR - http://www.scopus.com/inward/record.url?scp=0030951081&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030951081&partnerID=8YFLogxK

U2 - 10.1210/en.138.4.1559

DO - 10.1210/en.138.4.1559

M3 - Article

C2 - 9075716

AN - SCOPUS:0030951081

VL - 138

SP - 1559

EP - 1566

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 4

ER -